KLF4 and diabetic kidney disease: Berberine counteracts this dysregulation by inhibiting DNMT1 and DNMT3a expression in the kidney tissues of diabetic nephropathy mouse models, thereby preventing methylation of the KLF4 promoter, enhancing KLF4 transcription, and ameliorating renal injury [143].